NASDAQ:MASI - Masimo Stock Price, Price Target & More

$89.22 +0.49 (+0.55 %)
(As of 04/19/2018 04:00 PM ET)
Previous Close$89.22
Today's Range$88.2750 - $89.32
52-Week Range$80.69 - $104.71
Volume311,446 shs
Average Volume538,552 shs
Market Capitalization$4.57 billion
P/E Ratio36.42
Dividend YieldN/A
Beta0.94

About Masimo (NASDAQ:MASI)

Masimo logoMasimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation has a strategic partnership with NU Hospitals. The company was founded in 1989 and is headquartered in Irvine, California.

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000

Debt

Debt-to-Equity RatioN/A
Current Ratio3.72%
Quick Ratio3.09%

Price-To-Earnings

Trailing P/E Ratio36.42
Forward P/E Ratio31.75
P/E Growth2.32

Sales & Book Value

Annual Sales$798.11 million
Price / Sales5.77
Cash Flow$3.0691 per share
Price / Cash29.07
Book Value$13.68 per share
Price / Book6.52

Profitability

EPS (Most Recent Fiscal Year)$2.45
Net Income$131.61 million
Net Margins16.49%
Return on Equity22.75%
Return on Assets17.54%

Miscellaneous

Employees1,400
Outstanding Shares51,640,000

How to Become a New Pot Stock Millionaire

Masimo (NASDAQ:MASI) Frequently Asked Questions

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How were Masimo's earnings last quarter?

Masimo (NASDAQ:MASI) issued its earnings results on Tuesday, February, 27th. The medical equipment provider reported $0.72 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.61 by $0.11. The medical equipment provider earned $225.20 million during the quarter, compared to the consensus estimate of $201.54 million. Masimo had a return on equity of 22.75% and a net margin of 16.49%. The business's quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.46 earnings per share. View Masimo's Earnings History.

When is Masimo's next earnings date?

Masimo is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Masimo.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of $2.80 for the period, compared to the Thomson Reuters consensus estimate of $2.66. The company issued revenue guidance of $836.0 million, compared to the consensus revenue estimate of $832.07 million.

What price target have analysts set for MASI?

6 brokers have issued 1 year target prices for Masimo's stock. Their forecasts range from $91.00 to $112.00. On average, they expect Masimo's stock price to reach $102.1667 in the next year. View Analyst Ratings for Masimo.

Who are some of Masimo's key competitors?

Who are Masimo's key executives?

Masimo's management team includes the folowing people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 53)
  • Mr. Anand Sampath, Chief Operating Officer (Age 52)
  • Mr. Yongsam Lee, Exec. VP & Chief Information Officer (Age 53)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 45)
  • Dr. Steven J. Barker M.D., Ph.D., Acting Chief Medical Officer and Director (Age 73)

Has Masimo been receiving favorable news coverage?

Headlines about MASI stock have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Masimo earned a news sentiment score of 0.17 on Accern's scale. They also assigned news coverage about the medical equipment provider an impact score of 46.42 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $89.22.

How big of a company is Masimo?

Masimo has a market capitalization of $4.57 billion and generates $798.11 million in revenue each year. The medical equipment provider earns $131.61 million in net income (profit) each year or $2.45 on an earnings per share basis. Masimo employs 1,400 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]


MarketBeat Community Rating for Masimo (MASI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  231 (Vote Outperform)
Underperform Votes:  223 (Vote Underperform)
Total Votes:  454
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe MASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MASI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Masimo (NASDAQ:MASI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Masimo in the last 12 months. Their average twelve-month price target is $102.1667, suggesting that the stock has a possible upside of 14.51%. The high price target for MASI is $112.00 and the low price target for MASI is $91.00. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.832.572.57
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $102.1667$102.1667$97.00$97.00
Price Target Upside: 14.51% upside18.13% upside12.79% upside16.06% upside

Masimo (NASDAQ:MASI) Consensus Price Target History

Price Target History for Masimo (NASDAQ:MASI)

Masimo (NASDAQ:MASI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/9/2018BarclaysInitiated CoverageOverweight -> Overweight$97.00MediumView Rating Details
3/1/2018Piper JaffrayReiterated RatingHold$91.00HighView Rating Details
11/3/2017Stifel NicolausReiterated RatingBuy$108.00N/AView Rating Details
8/14/2017BTIG ResearchUpgradeNeutral -> Buy$100.00MediumView Rating Details
7/19/2017Roth CapitalBoost Price TargetBuy$96.00 -> $105.00LowView Rating Details
5/22/2017WedbushReiterated RatingOutperform$112.00LowView Rating Details
2/13/2017Raymond JamesDowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017CitigroupDowngradeMarket Perform$60.00N/AView Rating Details
(Data available from 4/19/2016 forward)

Earnings

Masimo (NASDAQ:MASI) Earnings History and Estimates Chart

Earnings by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ:MASI) Earnings Estimates

2018 EPS Consensus Estimate: $2.53
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.63$0.63$0.63
Q2 20181$0.65$0.65$0.65
Q3 20181$0.64$0.64$0.64
Q4 20181$0.61$0.61$0.61

Masimo (NASDAQ MASI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.66N/AView Earnings Details
2/27/2018Q4 2017$0.61$0.72$201.54 million$225.20 millionViewListenView Earnings Details
10/31/2017Q3 2017$0.53$0.70$189.01 million$193.69 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.71$0.83$189.03 million$192.90 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.60$0.82$184.14 million$186.30 millionViewListenView Earnings Details
2/14/2017Q416$0.52$0.51$180.48 million$183.20 millionViewListenView Earnings Details
11/2/2016Q316$0.42$0.52$165.51 million$167.60 millionViewListenView Earnings Details
8/3/2016Q216$0.41$0.57$166.02 million$172.64 millionViewListenView Earnings Details
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details
8/4/2015Q215$0.32$0.43$147.93 million$155.73 millionViewListenView Earnings Details
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details
8/7/2014Q214$0.29$0.27$145.76 million$140.92 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.39$144.01 million$139.80 millionViewListenView Earnings Details
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details
8/1/2012$0.28$0.27ViewN/AView Earnings Details
5/2/2012$0.28$0.27ViewN/AView Earnings Details
2/14/2012$0.23$0.23ViewN/AView Earnings Details
10/25/2011$0.27$0.24ViewN/AView Earnings Details
8/9/2011$0.28$0.28ViewN/AView Earnings Details
5/3/2011$0.30$0.30ViewN/AView Earnings Details
2/15/2011$0.26$0.29ViewN/AView Earnings Details
11/2/2010Q3 2010$0.25$0.27ViewN/AView Earnings Details
8/3/2010Q2 2010$0.25$0.25ViewN/AView Earnings Details
5/4/2010Q1 2010$0.23$0.24ViewN/AView Earnings Details
2/16/2010Q4 2009$0.22$0.23ViewN/AView Earnings Details
11/3/2009Q3 2009$0.21$0.22ViewN/AView Earnings Details
8/4/2009Q2 2009$0.21$0.22ViewN/AView Earnings Details
5/5/2009Q1 2009$0.19$0.22ViewN/AView Earnings Details
3/3/2009Q4 2008$0.18$0.24ViewN/AView Earnings Details
10/27/2008Q3 2008$0.16$0.22ViewN/AView Earnings Details
8/4/2008Q2 2008$0.14$0.18ViewN/AView Earnings Details
4/29/2008Q1 2008$0.11$0.15ViewN/AView Earnings Details
2/26/2008Q4 2007$0.13$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Masimo (NASDAQ:MASI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Masimo (NASDAQ MASI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 16.60%
Institutional Ownership Percentage: 82.77%
Insider Trading History for Masimo (NASDAQ:MASI)
Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ MASI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/2/2018Sanford FitchDirectorSell2,000$86.02$172,040.0066,249View SEC Filing  
3/29/2018Jon ColemanInsiderSell29,303$87.50$2,564,012.5020,504View SEC Filing  
3/13/2018Yongsam LeeEVPSell100$90.00$9,000.0071,100View SEC Filing  
2/1/2018Sanford FitchDirectorSell2,000$93.07$186,140.0068,249View SEC Filing  
2/1/2018Yongsam LeeEVPSell10,000$92.95$929,500.0079,000View SEC Filing  
1/25/2018Sanford FitchDirectorSell2,000$90.00$180,000.0070,249View SEC Filing  
1/5/2018Yongsam LeeEVPSell10,000$88.17$881,700.0075,018View SEC Filing  
12/4/2017Yongsam LeeEVPSell18,198$88.85$1,616,892.3070,800View SEC Filing  
12/1/2017Yongsam LeeEVPSell5,900$88.31$521,029.0070,800View SEC Filing  
11/9/2017Yongsam LeeEVPSell13,976$89.43$1,249,873.6874,000View SEC Filing  
11/1/2017Steven BarkerDirectorSell10,000$90.00$900,000.0073,249View SEC Filing  
11/1/2017Yongsam LeeEVPSell5,000$89.89$449,450.0074,000View SEC Filing  
8/17/2017Sanford FitchDirectorSell11,000$87.25$959,750.0072,249View SEC Filing  
7/20/2017Jon ColemanInsiderSell25,000$97.50$2,437,500.0032,201View SEC Filing  
7/14/2017Rick FishelInsiderSell15,000$94.85$1,422,750.0035,022View SEC Filing  
7/13/2017Sanford FitchDirectorSell6,000$91.89$551,340.0089,249View SEC Filing  
7/11/2017Anand SampathCOOSell40,000$92.00$3,680,000.0020,000View SEC Filing  
7/11/2017Rick FishelInsiderSell15,000$92.85$1,392,750.0035,022View SEC Filing  
6/29/2017Sanford FitchDirectorSell14,000$92.06$1,288,840.0090,249View SEC Filing  
5/1/2017Joe E KianiCEOSell145,841$102.37$14,929,743.17165,082View SEC Filing  
4/28/2017Thomas Samuel McclenahanEVPSell8,000$102.75$822,000.002,000View SEC Filing  
4/26/2017Joe E KianiCEOSell154,159$99.70$15,369,652.30219,241View SEC Filing  
4/25/2017Joe E KianiCEOSell13,201$101.00$1,333,301.00219,241View SEC Filing  
4/25/2017Jon ColemanInsiderSell50,000$100.00$5,000,000.0014,682View SEC Filing  
4/25/2017Yongsam LeeEVPSell10,000$100.00$1,000,000.0079,000View SEC Filing  
4/24/2017Joe E KianiCEOSell100,000$99.00$9,900,000.00219,241View SEC Filing  
4/24/2017Thomas Samuel McclenahanEVPSell10,000$98.75$987,500.0010,000View SEC Filing  
4/20/2017Thomas Samuel McclenahanEVPSell10,000$95.75$957,500.004,000View SEC Filing  
4/19/2017Yongsam LeeEVPSell10,000$95.00$950,000.0079,000View SEC Filing  
4/4/2017Raad Mark DeCFOSell48,000$93.25$4,476,000.0014,660View SEC Filing  
3/22/2017Sanford FitchDirectorSell3,000$93.23$279,690.0080,000View SEC Filing  
3/10/2017Paul JansenEVPSell55,611$94.47$5,253,571.1710,000View SEC Filing  
3/9/2017Ramshorst David J VanInsiderSell7,500$94.20$706,500.002,500View SEC Filing  
2/23/2017Raad Mark DeCFOSell30,000$86.25$2,587,500.0017,660View SEC Filing  
2/17/2017Raad Mark DeCFOSell45,000$80.00$3,600,000.0017,660View SEC Filing  
2/16/2017Joe E KianiCEOSell300,000$80.04$24,012,000.00119,241View SEC Filing  
2/3/2017Jon ColemanInsiderSell6,000$75.00$450,000.0013,182View SEC Filing  
2/3/2017Raad Mark DeCFOSell15,000$75.00$1,125,000.0017,660View SEC Filing  
1/27/2017Jon ColemanInsiderSell5,800$72.50$420,500.008,707View SEC Filing  
1/27/2017Raad Mark DeCFOSell15,000$72.50$1,087,500.0017,660View SEC Filing  
1/20/2017Jon ColemanInsiderSell200$72.50$14,500.007,282View SEC Filing  
1/13/2017Yongsam LeeEVPSell10,000$72.00$720,000.0079,000View SEC Filing  
1/10/2017Jon ColemanInsiderSell6,000$70.00$420,000.0013,182View SEC Filing  
1/10/2017Raad Mark DeCFOSell15,000$70.00$1,050,000.0017,660View SEC Filing  
1/10/2017Yongsam LeeEVPSell10,000$70.00$700,000.0079,000View SEC Filing  
1/9/2017Paul JansenEVPSell17,945$68.88$1,236,051.6017,945View SEC Filing  
1/3/2017Ramshorst David J VanInsiderSell4,000$67.20$268,800.005,000View SEC Filing  
12/27/2016Paul JansenEVPSell2,055$68.88$141,548.402,055View SEC Filing  
12/21/2016Jon ColemanInsiderSell4,000$67.50$270,000.004,459View SEC Filing  
12/16/2016Thomas Samuel McclenahanEVPSell10,000$66.00$660,000.0010,000View SEC Filing  
12/8/2016Paul JansenEVPSell10,000$63.88$638,800.005,000View SEC Filing  
12/7/2016Thomas Samuel McclenahanEVPSell2,293$63.00$144,459.004,000View SEC Filing  
12/6/2016Joe E KianiCEOSell52,859$62.03$3,278,843.77119,241View SEC Filing  
12/6/2016Thomas Samuel McclenahanEVPSell4,000$63.00$252,000.004,000View SEC Filing  
12/1/2016Joe E KianiCEOSell36,119$62.06$2,241,545.14119,241View SEC Filing  
11/29/2016Joe E KianiCEOSell104,870$62.27$6,530,254.90119,241View SEC Filing  
11/23/2016Joe E KianiCEOSell85,771$62.06$5,322,948.26119,241View SEC Filing  
11/22/2016Joe E KianiCEOSell869$62.00$53,878.00119,241View SEC Filing  
11/21/2016Joe E KianiCEOSell30,462$62.04$1,889,862.48119,241View SEC Filing  
11/18/2016Joe E KianiCEOSell20,381$62.02$1,264,029.62119,241View SEC Filing  
11/1/2016Anand SampathCOOSell65,000$55.04$3,577,600.0023,171View SEC Filing  
10/31/2016Anand SampathCOOSell51,345$55.05$2,826,542.2523,171View SEC Filing  
10/19/2016Sanford FitchDirectorSell2,000$59.05$118,100.0046,000View SEC Filing  
10/10/2016Joe E KianiCEOSell84,617$60.26$5,099,020.42126,450View SEC Filing  
10/10/2016Yongsam LeeEVPSell30,000$60.50$1,815,000.0093,000View SEC Filing  
10/5/2016Sanford FitchDirectorSell2,000$59.58$119,160.0048,000View SEC Filing  
10/4/2016Joe E KianiCEOSell4,300$60.07$258,301.00121,441View SEC Filing  
10/3/2016Joe E KianiCEOSell2,200$60.00$132,000.00121,441View SEC Filing  
9/30/2016Thomas Samuel McclenahanEVPSell10,000$59.00$590,000.0010,000View SEC Filing  
9/27/2016Joe E KianiCEOSell4,464$60.01$267,884.64123,705View SEC Filing  
9/22/2016Joe E KianiCEOSell49,484$60.18$2,977,947.12158,911View SEC Filing  
9/21/2016Sanford FitchDirectorSell2,000$59.41$118,820.0050,000View SEC Filing  
9/20/2016Joe E KianiCEOSell400$60.16$24,064.00120,240View SEC Filing  
9/19/2016Joe E KianiCEOSell999$60.03$59,969.97120,240View SEC Filing  
9/7/2016Joe E KianiCEOSell33,536$60.00$2,012,160.00152,777View SEC Filing  
9/7/2016Jon ColemanInsiderSell6,000$60.00$360,000.00759View SEC Filing  
9/7/2016Sanford FitchDirectorSell2,000$59.81$119,620.00View SEC Filing  
8/17/2016Sanford FitchDirectorSell2,000$58.11$116,220.0054,000View SEC Filing  
8/4/2016Jon ColemanInsiderSell22,000$56.82$1,250,040.0010,459View SEC Filing  
8/4/2016Paul JansenEVPSell10,000$58.88$588,800.0010,000View SEC Filing  
8/3/2016Sanford FitchDirectorSell2,000$52.62$105,240.0056,000View SEC Filing  
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.0042,022View SEC Filing  
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.0058,000View SEC Filing  
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.003,000View SEC Filing  
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00175,818View SEC Filing  
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68313,797View SEC Filing  
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.004,459View SEC Filing  
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.0042,660View SEC Filing  
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.0052,022View SEC Filing  
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.004,459View SEC Filing  
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.0010,000View SEC Filing  
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.004,459View SEC Filing  
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00133,000View SEC Filing  
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00133,000View SEC Filing  
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00133,000View SEC Filing  
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.0042,660View SEC Filing  
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.0042,660View SEC Filing  
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00459View SEC Filing  
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.0061,000View SEC Filing  
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.0061,000View SEC Filing  
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00459View SEC Filing  
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.0061,000View SEC Filing  
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.0061,000View SEC Filing  
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Masimo (NASDAQ MASI) News Headlines

Source:
DateHeadline
in Post-operative Red Blood Cell (RBC) Transfusion Best Practicesin Post-operative Red Blood Cell (RBC) Transfusion Best Practices
www.businesswire.com - April 19 at 3:46 PM
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best PracticesNew Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
finance.yahoo.com - April 19 at 3:46 PM
Masimo (MASI) Upgraded by BidaskClub to BuyMasimo (MASI) Upgraded by BidaskClub to Buy
www.americanbankingnews.com - April 18 at 5:48 PM
 Brokerages Expect Masimo (MASI) to Post $0.70 Earnings Per Share Brokerages Expect Masimo (MASI) to Post $0.70 Earnings Per Share
www.americanbankingnews.com - April 18 at 3:08 PM
Masimo to Report First Quarter 2018 Financial Results after Market Close on Wednesday, May 2Masimo to Report First Quarter 2018 Financial Results after Market Close on Wednesday, May 2
finance.yahoo.com - April 18 at 10:28 AM
Financial Analysis: IMRIS (IMRSQ) and Masimo (MASI)Financial Analysis: IMRIS (IMRSQ) and Masimo (MASI)
www.americanbankingnews.com - April 15 at 9:24 PM
BidaskClub Downgrades Masimo (MASI) to HoldBidaskClub Downgrades Masimo (MASI) to Hold
www.americanbankingnews.com - April 14 at 10:19 PM
Comparing Masimo (MASI) & Its CompetitorsComparing Masimo (MASI) & Its Competitors
www.americanbankingnews.com - April 14 at 5:09 PM
BRIEF-Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter With Integrated NomoLine CapnographyBRIEF-Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter With Integrated NomoLine Capnography
www.reuters.com - April 12 at 11:22 AM
BidaskClub Lowers Masimo (MASI) to SellBidaskClub Lowers Masimo (MASI) to Sell
www.americanbankingnews.com - April 11 at 9:31 PM
Masimo Gets CE Mark for NomoLine, Expands in CapnographyMasimo Gets CE Mark for NomoLine, Expands in Capnography
finance.yahoo.com - April 11 at 11:04 AM
Masimo (MASI) Raised to "Buy" at BTIG ResearchMasimo (MASI) Raised to "Buy" at BTIG Research
www.americanbankingnews.com - April 10 at 5:37 PM
Masimo Announces CE Marking of Rad-97™ Pulse CO-OximeterMasimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter
www.businesswire.com - April 10 at 3:43 PM
Why Masimo (MASI) Could Beat Earnings Estimates Again April 09, 2018Why Masimo (MASI) Could Beat Earnings Estimates Again April 09, 2018
www.zacks.com - April 9 at 3:46 PM
Masimo (MASI) and The Competition Critical AnalysisMasimo (MASI) and The Competition Critical Analysis
www.americanbankingnews.com - April 9 at 1:25 PM
Why Masimo (MASI) Could Beat Earnings Estimates AgainWhy Masimo (MASI) Could Beat Earnings Estimates Again
finance.yahoo.com - April 9 at 10:43 AM
Masimo (MASI) Receives Consensus Rating of "Buy" from AnalystsMasimo (MASI) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 8 at 1:17 AM
Critical Contrast: Masimo (MASI) and Its CompetitorsCritical Contrast: Masimo (MASI) and Its Competitors
www.americanbankingnews.com - April 6 at 11:27 AM
Masimo (MASI) Launches UniView, Improves Patient SafetyMasimo (MASI) Launches UniView, Improves Patient Safety
finance.yahoo.com - April 4 at 5:48 PM
Contrasting Masimo (MASI) & Its RivalsContrasting Masimo (MASI) & Its Rivals
www.americanbankingnews.com - April 4 at 5:20 PM
Reviewing Masimo (MASI) & Its PeersReviewing Masimo (MASI) & Its Peers
www.americanbankingnews.com - April 4 at 3:06 AM
Form 4 MASIMO CORP For: Mar 29 Filed by: Coleman JonForm 4 MASIMO CORP For: Mar 29 Filed by: Coleman Jon
www.streetinsider.com - April 3 at 10:44 AM
Investors Buy High Volume of Call Options on Masimo (MASI)Investors Buy High Volume of Call Options on Masimo (MASI)
www.americanbankingnews.com - April 3 at 7:35 AM
Zacks: Brokerages Expect Masimo Co. (MASI) Will Post Quarterly Sales of $206.24 MillionZacks: Brokerages Expect Masimo Co. (MASI) Will Post Quarterly Sales of $206.24 Million
www.americanbankingnews.com - April 3 at 3:21 AM
Insider Selling: Masimo Co. (MASI) Director Sells 2,000 Shares of StockInsider Selling: Masimo Co. (MASI) Director Sells 2,000 Shares of Stock
www.americanbankingnews.com - April 2 at 10:42 PM
Insider Selling: Masimo Co. (MASI) Insider Sells 29,303 Shares of StockInsider Selling: Masimo Co. (MASI) Insider Sells 29,303 Shares of Stock
www.americanbankingnews.com - April 2 at 10:23 PM
Masimo Announces UniView™Masimo Announces UniView™
www.businesswire.com - April 2 at 10:55 AM
Masimo Co. (MASI) Expected to Post Earnings of $0.70 Per ShareMasimo Co. (MASI) Expected to Post Earnings of $0.70 Per Share
www.americanbankingnews.com - April 1 at 3:20 PM
Masimo (MASI) Shares Cross Above 200 DMAMasimo (MASI) Shares Cross Above 200 DMA
www.nasdaq.com - March 30 at 10:36 AM
Masimo Corporation (NASDAQ:MASI): Will The Growth Last?Masimo Corporation (NASDAQ:MASI): Will The Growth Last?
finance.yahoo.com - March 30 at 10:36 AM
Masimo (MASI) Upgraded to "Hold" at BidaskClubMasimo (MASI) Upgraded to "Hold" at BidaskClub
www.americanbankingnews.com - March 24 at 4:30 PM
 Analysts Expect Masimo Co. (MASI) to Post $0.70 Earnings Per Share Analysts Expect Masimo Co. (MASI) to Post $0.70 Earnings Per Share
www.americanbankingnews.com - March 15 at 11:22 AM
Toshiba partners with Atheer to provide enterprise-grade Augmented Reality (AR) software platform for Toshibas new dynaEdge™ AR Smart GlassesToshiba partners with Atheer to provide enterprise-grade Augmented Reality (AR) software platform for Toshiba's new dynaEdge™ AR Smart Glasses
www.bizjournals.com - March 15 at 11:10 AM
Masimo Co. (MASI) Receives Consensus Rating of "Buy" from BrokeragesMasimo Co. (MASI) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - March 14 at 1:40 AM
New Study Investigates the Performance of Masimo SpHb® During ... - Business Wire (press release)New Study Investigates the Performance of Masimo SpHb® During ... - Business Wire (press release)
www.businesswire.com - March 12 at 8:01 AM
What’s Masimo’s Business Strategy?What’s Masimo’s Business Strategy?
finance.yahoo.com - March 10 at 11:15 AM
Barclays Begins Coverage on Masimo (MASI)Barclays Begins Coverage on Masimo (MASI)
www.americanbankingnews.com - March 10 at 12:00 AM
Masimo’s Financial Performance in Fiscal 2017Masimo’s Financial Performance in Fiscal 2017
finance.yahoo.com - March 9 at 12:27 PM
Masimo to Present at Barclays Global Healthcare ConferenceMasimo to Present at Barclays Global Healthcare Conference
finance.yahoo.com - March 7 at 11:11 AM
Masimo (MASI) Upgraded to Buy at Zacks Investment ResearchMasimo (MASI) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - March 6 at 2:07 PM
Masimo Announces Replica™Masimo Announces Replica™
finance.yahoo.com - March 6 at 10:45 AM
USA Financial Portformulas Corp Has $1.18 Million Stake in Masimo Co. (MASI)USA Financial Portformulas Corp Has $1.18 Million Stake in Masimo Co. (MASI)
www.americanbankingnews.com - March 5 at 3:05 PM
Masimo (MASI) Rating Lowered to Hold at Zacks Investment ResearchMasimo (MASI) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - March 5 at 1:36 PM
Arizona State Retirement System Has $2.90 Million Holdings in Masimo Co. (MASI)Arizona State Retirement System Has $2.90 Million Holdings in Masimo Co. (MASI)
www.americanbankingnews.com - March 5 at 4:38 AM
Rhumbline Advisers Sells 8,878 Shares of Masimo Co. (MASI)Rhumbline Advisers Sells 8,878 Shares of Masimo Co. (MASI)
www.americanbankingnews.com - March 4 at 11:05 AM
The Manufacturers Life Insurance Company  Has $9.46 Million Stake in Masimo Co. (MASI)The Manufacturers Life Insurance Company Has $9.46 Million Stake in Masimo Co. (MASI)
www.americanbankingnews.com - March 4 at 9:30 AM
Masimo Co. (MASI) Shares Sold by Allianz Asset Management GmbHMasimo Co. (MASI) Shares Sold by Allianz Asset Management GmbH
www.americanbankingnews.com - March 4 at 4:18 AM
California Public Employees Retirement System Acquires 11,178 Shares of Masimo Co. (MASI)California Public Employees Retirement System Acquires 11,178 Shares of Masimo Co. (MASI)
www.americanbankingnews.com - March 3 at 5:12 AM
Masimo Co. (MASI) Shares Sold by Bank of New York Mellon CorpMasimo Co. (MASI) Shares Sold by Bank of New York Mellon Corp
www.americanbankingnews.com - March 3 at 4:42 AM
Masimo Co. (MASI) Shares Bought by Fuller & Thaler Asset Management Inc.Masimo Co. (MASI) Shares Bought by Fuller & Thaler Asset Management Inc.
www.americanbankingnews.com - March 2 at 7:00 AM

SEC Filings

Masimo (NASDAQ:MASI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Masimo (NASDAQ:MASI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Masimo (NASDAQ MASI) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.